Peptide Vaccination in Patients with Acute Myeloid Leukemia

被引：0
|
作者：
Schmitt, M. [1 ]
Schmitt, A. [1 ]
Casalegno-Garduno, R. [1 ]
机构：
[1] Univ Rostock, D-2500 Rostock 1, Germany
来源：
ANNALS OF HEMATOLOGY | 2011年 / 90卷
关键词：
MYELODYSPLASTIC SYNDROME;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S66 / S68
页数：3
相关论文
共 50 条
  • [1] Peptide vaccination in patients with acute leukemia
    Schmitt, M.
    ONKOLOGIE, 2010, 33 : 196 - 197
  • [2] Peptide vaccination of myeloid leukemia
    Kurbegov, D
    Molldrem, JJ
    REGENERATIVE AND CELL THERAPY: CLINICAL ADVANCES, 2005, (11): : 131 - 144
  • [3] Peptide vaccines for patients with acute myeloid leukemia
    Schmitt, Michael
    Casalegno-Garduno, Rosaely
    Xu, Xun
    Schmitt, Anita
    EXPERT REVIEW OF VACCINES, 2009, 8 (10) : 1415 - 1425
  • [4] Clinical and immune responses of WT1-peptide vaccination in patients with acute myeloid leukemia.
    Keilholz, U.
    Letsch, A.
    Asemissen, A.
    Hofmann, W.
    Uharek, L.
    Blau, W.
    Thiel, E.
    Scheibenbogen, C.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 102S - 102S
  • [5] Dendritic cell vaccination in acute myeloid leukemia
    Anguille, Sebastien
    Willemen, Yannick
    Lion, Eva
    Smits, Evelien L.
    Berneman, Zwi N.
    CYTOTHERAPY, 2012, 14 (06) : 647 - 656
  • [6] WT1-peptide vaccination shows high immunogenicity and clinical activity in patients with acute myeloid leukemia.
    Keilholz, U
    Scheibenbogen, C
    Letsch, A
    Asemissen, AM
    Hofmann, WK
    Uharek, L
    Wolfgang, B
    Eckhard, T
    BLOOD, 2005, 106 (11) : 122A - 122A
  • [7] Long-term WT1 peptide vaccination for patients with acute myeloid leukemia with minimal residual disease
    A Tsuboi
    Y Oka
    T Kyo
    Y Katayama
    O A Elisseeva
    M Kawakami
    S Nishida
    S Morimoto
    A Murao
    H Nakajima
    N Hosen
    Y Oji
    H Sugiyama
    Leukemia, 2012, 26 : 1410 - 1413
  • [8] Long-term WT1 peptide vaccination for patients with acute myeloid leukemia with minimal residual disease
    Tsuboi, A.
    Oka, Y.
    Kyo, T.
    Katayama, Y.
    Elisseeva, O. A.
    Kawakami, M.
    Nishida, S.
    Morimoto, S.
    Murao, A.
    Nakajima, H.
    Hosen, N.
    Oji, Y.
    Sugiyama, H.
    LEUKEMIA, 2012, 26 (06) : 1410 - 1413
  • [9] WT1-peptide vaccination in patients with acute myeloid leukemia shows high immunogenicity associated with clinical activity
    Letsch, N
    Keilholz, U
    Asemissen, AM
    Bauer, S
    Thiel, E
    Scheibenbogen, C
    JOURNAL OF IMMUNOTHERAPY, 2005, 28 (06) : 631 - 632
  • [10] High-Dose RHAMM-R3 Peptide Peptide Vaccination for Patients with Vaccination for Patients with Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), Multiple Myeloma (MM) and Chronic Lymphocytic Leukemia (CLL)
    Greiner, Jochen
    Schmitt, Anita
    Giannopoulos, Krzysztof
    Funk, Isabel
    Heyduk, Marta
    Rojewski, Markus
    Chen, Jinfei
    Goetz, Marlies
    Bommer, Martin
    Ritter, Gerd
    Guillaume, Phillipe
    Dmoszynska, Anna
    Doehner, Hartmut
    Schmitt, Michael
    BLOOD, 2008, 112 (11) : 1001 - 1001
12345